Iranian Journal of Pharmaceutical Research (2004): Supplement 2:
2nd International Congress on Traditional Medicine and Materia Medica
Treatment of severe pain in cancer patients by Carcinosinum30C, a homeopathic approach, seven case reports
Sadray S.1, Fani H.2
1Tehran University of Medical Sciences, School of Pharmacy, Tehran, Iran 2Baghiyatollah Hospital and University, Tehran, Iran
Neuropathic pain and its effective management remains a challenging clinical problem in palliative care of cancer patients. In this study Carcinosinum30c (a homeopathic remedy) is used for relief of severe pain in cancer patients, who were a candidate for nerve block procedure (CEPCA).
In this case study to seven cancer patients who were referred to pain clinic for nerve block procedure, after patient consent, one granule of carcinosinum30c (30c = 10-60 diluted with succession) was administrated sublingually. The efficacy of the remedy was evaluated qualitative and by pain scores. If the pain ceases completely after carcinosinum30c (pain score <3), it means a positive effect.
Case 1: A 38-year woman with metastatic mesothelioma
Case 2: A 18-year man with sever abdomen and extremities pain due adenocarcinoma of colon with metastasis to many organs.
Case 3: A 28-year woman with metastatic breast cancer and sever pain not responding to 10 mg morphine IV each two hours.
Case 4: A 85-year man with metastatic adenocarcinoma of prostate.
Case 5: A 58-year man with metastatic adenocarcinoma of prostate.
Case 6: A 58-year woman with metastatic adenocarcinoma of ovary and uterus.
Case 7: A 27-year man with metastatic adenocarcinoma of colorectal
Five patients in these case reports experienced clinically significant pain relief, no need for nerve block procedure and no need for analgesics with no detectable adverse events with Carcinosinum30c.
In two patients the analgesic dosage was significantly reduced.
It seems carcinosinum 30c is an effective palliative homeopathic remedy in pain relief of severe pain in cancer patients.
For establishing an exact protocol about when and how frequent, as solution or sublingually, in all or special groups of patients and etc., well-designed studies (e.g. controlled clinical trials, randomizing the patients, evaluating pain scores before and after remedy intake, etc.) are needed to support the findings obtained in these case reports.